Meanwhile, the activation of PI3K/AKT by IGF-1 can also inhibit ubiquitin-mediated degradation of proteins and apoptosis in skeletal muscle cells, reduce necrosis of muscle tissue, and thus alleviate the development of sarcopenia and its comorbidities (59, 60). This evidence concerns the gene AKT1 and sarcopenia.